authors
- McWhirter, Elaine
- Hamid, Omid
- Chmielowski, Bartosz
- Carvajal, Richard D
- Jaffray, David A
- Driscoll, Brandon
- Shek, Tina
- Yeung, Ivan
- Keller, Harald
- McKee, Trevor D
- Pearce, Tillman E
- Kroll, Stew
- Joshua, Anthony M
A Phase 2 biomarker-enriched study of evofosfamide (TH-302) in patients with advanced melanoma.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- May 20, 2015
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal